Novavax aims for name recognition in new vaccines campaign

Novavax aims for name recognition in new vaccines campaign

Source: 
Endpoints
snippet: 

After suffering delay after delay, Novavax finally made it to the FDA back in January with its protein-based Covid-19 vaccine. But the Maryland-based company isn’t waiting for an authorization to get its name out there.